Literature DB >> 12116987

Hypertension guidelines in elderly patients: is anybody listening?

Karen Tu1, Muhammad M Mamdani, Jack V Tu.   

Abstract

PURPOSE: Previous guidelines for the management of uncomplicated hypertension in elderly patients have recommended diuretic agents and then beta-blockers. We examined trends in the initial treatment choice for elderly people with hypertension and the effects of a government-sponsored program to publish and disseminate a simplified version of the national guidelines for the treatment of hypertension to all physicians in Ontario, Canada. SUBJECTS AND METHODS: Linked administrative databases containing information on the more than 1.2 million elderly residents in Ontario were used. Time series analysis was performed to determine prescribing trends from 1993 to 1998 for patients who began antihypertensive medication for the treatment of hypertension and to examine the effects of the simplified guidelines that were distributed in July of 1995.
RESULTS: Diuretic agents were the most commonly prescribed medications, with annual rates from 35% to 38% (P = 0.59) throughout the study. Beta-blocker prescribing rose from 12% to 16% (P <0.01), whereas angiotensin-converting enzyme (ACE) inhibitor prescribing rose from 27% to 32% (P <0.01). Prescriptions for calcium channel blockers dropped significantly, from 23% to 14% (P <0.01). However, the publication and dissemination of the Ontario hypertension guidelines had no statistically significant effects on the proportion of patients who began treatment with a diuretic agent (P = 0.55), beta-blocker, (P = 0.32), ACE inhibitor (P = 0.09), or calcium channel blocker (P = 0.07).
CONCLUSION: The dissemination of simplified practice guidelines for hypertension did not have notable effects on prescribing patterns in Ontario.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116987     DOI: 10.1016/s0002-9343(02)01144-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  The Canadian Hypertension Education Program--a unique Canadian initiative.

Authors:  F A McAlister
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

2.  The Canadian Hypertension Education Program (CHEP) recommendations: launching a new series.

Authors:  Finlay A McAlister; Eric Wooltorton; Norman R C Campbell
Journal:  CMAJ       Date:  2005-08-30       Impact factor: 8.262

3.  Evaluation of a toolkit to improve cardiovascular disease screening and treatment for people with type 2 diabetes: protocol for a cluster-randomized pragmatic trial.

Authors:  Baiju R Shah; Onil Bhattacharyya; Catherine Yu; Muhammad Mamdani; Janet A Parsons; Sharon E Straus; Merrick Zwarenstein
Journal:  Trials       Date:  2010-04-23       Impact factor: 2.279

4.  A multicenter, case-control study of the effects of antihypertensive therapy on orthostatic hypotension, postprandial hypotension, and falls in octo- and nonagenarians in residential care facilities.

Authors:  Alex A Fisher; Allan J McLean; Michael W Davis; David G Le Couteur
Journal:  Curr Ther Res Clin Exp       Date:  2003-03

5.  Prevalence, treatment, and control of hypertension in primary care: gaps, trends, and opportunities.

Authors:  Robert J Petrella; Elizabeth P Merikle; Jared Jones
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-01       Impact factor: 3.738

6.  Clinical and nonclinical correlates of adherence to prescribing guidelines for hypertension in a large managed care organization.

Authors:  Philip C Skelding; Sumit R Majumdar; Ken Kleinman; Cheryl Warner; Susanne Salem-Schatz; Irina Miroshnik; Lisa Prosser; Steven R Simon
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-06       Impact factor: 3.738

7.  Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK.

Authors:  Tom Walley; Andy K Duggan; Alan R Haycox; Christie J Niziol
Journal:  J R Soc Med       Date:  2003-11       Impact factor: 18.000

8.  Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP).

Authors:  Janusz Kaczorowski; Larry W Chambers; Lisa Dolovich; J Michael Paterson; Tina Karwalajtys; Tracy Gierman; Barbara Farrell; Beatrice McDonough; Lehana Thabane; Karen Tu; Brandon Zagorski; Ron Goeree; Cheryl A Levitt; William Hogg; Stephanie Laryea; Megan Ann Carter; Dana Cross; Rolf J Sabaldt
Journal:  BMJ       Date:  2011-02-07

9.  The Ontario printed educational message (OPEM) trial to narrow the evidence-practice gap with respect to prescribing practices of general and family physicians: a cluster randomized controlled trial, targeting the care of individuals with diabetes and hypertension in Ontario, Canada.

Authors:  Merrick Zwarenstein; Janet E Hux; Diane Kelsall; Michael Paterson; Jeremy Grimshaw; Dave Davis; Andreas Laupacis; Michael Evans; Peter C Austin; Pamela M Slaughter; Susan K Shiller; Ruth Croxford; Karen Tu
Journal:  Implement Sci       Date:  2007-11-26       Impact factor: 7.327

10.  Impact of ethnic-specific guidelines for anti-hypertensive prescribing in primary care in England: a longitudinal study.

Authors:  Lena Barrera; Craig Leaper; Utz J Pape; Azeem Majeed; Marta Blangiardo; Christopher Millett
Journal:  BMC Health Serv Res       Date:  2014-02-25       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.